X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1777) 1777
Paper (726) 726
Publication (491) 491
Report (212) 212
Patent (197) 197
Art (46) 46
Book / eBook (32) 32
Conference Proceeding (23) 23
Newspaper Article (18) 18
Magazine Article (17) 17
Book Review (14) 14
Book Chapter (6) 6
Data Set (6) 6
Dissertation (6) 6
Compact Disc (3) 3
Web Resource (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (770) 770
cern lhc coll (752) 752
experimental results (744) 744
physics (711) 711
particle physics (689) 689
high energy physics - experiment (674) 674
physics - high energy physics - experiment (607) 607
cms (588) 588
p p: scattering (581) 581
high energy physics (524) 524
p p: colliding beams (521) 521
physics of elementary particles and fields (381) 381
13000 gev-cms (372) 372
phenomenology (343) 343
particle physics - experiment (267) 267
scattering [p p] (258) 258
hep (256) 256
8000 gev-cms (235) 235
colliding beams [p p] (221) 221
nuclear experiment (217) 217
hadron-hadron scattering (208) 208
background (206) 206
humans (173) 173
index medicus (159) 159
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (148) 148
ex (147) 147
chemistry (135) 135
metallurgy (132) 132
supersymmetry (130) 130
chemical surface treatment (120) 120
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (120) 120
coating by vacuum evaporation, by sputtering, by ionimplantation or by chemical vapour deposition, in general (120) 120
coating material with metallic material (120) 120
coating metallic material (120) 120
diffusion treatment of metallic material (120) 120
inhibiting corrosion of metallic material or incrustation ingeneral (120) 120
surface treatment of metallic material by diffusion into thesurface, by chemical conversion or substitution (119) 119
transverse momentum: missing-energy (118) 118
channel cross section: upper limit (115) 115
physics, particles & fields (115) 115
cern lab (110) 110
final state:jet lepton (105) 105
mass dependence (103) 103
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (102) 102
male (96) 96
astrophysics (92) 92
elementary particles, quantum field theory (92) 92
female (92) 92
quantum field theories, string theory (92) 92
transverse momentum dependence (92) 92
data analysis method (87) 87
jet: bottom (86) 86
kinematics (83) 83
top: pair production (83) 83
bottom: particle identification (82) 82
classical and quantum gravitation, relativity theory (80) 80
quantum physics (79) 79
rapidity dependence (79) 79
high energy astrophysical phenomena (75) 75
performing operations (75) 75
transporting (75) 75
channel cross section: branching ratio: upper limit (70) 70
z0: leptonic decay (70) 70
astronomy & astrophysics (68) 68
higgs particle: hadroproduction (68) 68
nuclear physics (68) 68
final state:jet dilepton (67) 67
muon: pair production (66) 66
adult (64) 64
mechanical metal-working without essentially removingmaterial (62) 62
punching metal (62) 62
quantum chromodynamics: perturbation theory (62) 62
instrumentation and detectors (61) 61
jet: transverse momentum (61) 61
114 physical sciences (60) 60
channel cross section: measured (58) 58
middle aged (58) 58
mass spectrum: (57) 57
animals (56) 56
nuclear and high energy physics (55) 55
squark: pair production (55) 55
differential cross section: measured (54) 54
mass: lower limit (53) 53
transverse momentum (53) 53
architecture (52) 52
bottom: pair production (52) 52
electroweak interaction (52) 52
lead (50) 50
new physics: search for (50) 50
aged (49) 49
sensitivity (48) 48
upper limit [channel cross section] (48) 48
final state:jet (47) 47
jet lepton (47) 47
numerical calculations: monte carlo (47) 47
w: leptonic decay (47) 47
architecture, modern--designs and plans (46) 46
avery architectural and fine arts library (46) 46
beyond standard model (46) 46
columbia university. graduate school of architecture, planning, and preservation (46) 46
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Online Resources - Online (5) 5
Music - Circulation Desk (3) 3
UTL at Downsview - May be requested (3) 3
Art - Library use only (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Shipping from publisher (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Storage (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1951) 1951
German (414) 414
French (61) 61
Spanish (20) 20
Chinese (16) 16
Portuguese (13) 13
Korean (2) 2
Swedish (2) 2
Japanese (1) 1
Latin (1) 1
Polish (1) 1
Russian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Environmental Research and Public Health, ISSN 1661-7827, 06/2018, Volume 15, Issue 6, p. 1263
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2006, Volume 103, Issue 28, pp. 10729 - 10734
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e95970
Salinomycin raised hope to be effective in anti-cancer therapies due to its capability to overcome apoptosis-resistance in several types of cancer cells.... 
CANCER-CELLS | SURVIVAL | APOPTOSIS | MAINTENANCE | HEPATOCYTES | ACTIVATION | THYMIDINE ANALOGS | MULTIDISCIPLINARY SCIENCES | MITOCHONDRIA | GROWTH | INDUCTION | Reactive Oxygen Species - metabolism | Microtubule-Associated Proteins - genetics | Apoptosis - drug effects | Microtubule-Associated Proteins - metabolism | Humans | Green Fluorescent Proteins - genetics | Hepatocytes - metabolism | Autophagy - drug effects | Dose-Response Relationship, Drug | Hepatocytes - cytology | Flow Cytometry | RNA Interference | Carcinoma, Hepatocellular - genetics | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacology | Autophagy - genetics | Pyrans - pharmacology | Hepatocytes - drug effects | Cell Survival - drug effects | Green Fluorescent Proteins - metabolism | Ubiquitin-Activating Enzymes - genetics | Liver Neoplasms - genetics | Cells, Cultured | Blotting, Western | Hep G2 Cells | Autophagy-Related Protein 7 | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Coccidiostats - pharmacology | Carcinoma, Hepatocellular - metabolism | Mitochondrial DNA | Hepatoma | Health aspects | Apoptosis | Cytochrome | Leukemia | Hepatocellular carcinoma | Infections | Autophagy | Accumulation | Medical schools | Anticancer properties | Liver cancer | Mitochondria | Immunology | Surgery | Inhibition | Starvation | Rheumatology | Pharmacology | Exposure | Cytometry | Salinomycin | Antibiotics | Hepatocytes | In vivo methods and tests | Viability | Phagocytosis | Cancer
Journal Article
European Journal of Immunology, ISSN 0014-2980, 10/2017, Volume 47, Issue 10, pp. 1819 - 1834
Journal Article